For: | Choi YI, Chung JW, Kim KO, Kwon KA, Kim YJ, Kim JH, Seo JY, Park DK. Tailored eradication strategy vs concomitant therapy for Helicobacter pylori eradication treatment in Korean patients. World J Gastroenterol 2021; 27(31): 5247-5258 [PMID: 34497448 DOI: 10.3748/wjg.v27.i31.5247] |
---|---|
URL: | https://www.wjgnet.com/2220-3192/full/v27/i31/5247.htm |
Number | Citing Articles |
1 |
Kaihao Lin, Lifang Huang, Yadong Wang, Kangkang Li, Yuanning Ye, Siqi Yang, Aimin Li. Efficacy of genotypic susceptibility‐guided tailored therapy for Helicobacter pylori infection: A systematic review and single arm meta‐analysis. Helicobacter 2023; 28(6) doi: 10.1111/hel.13015
|
2 |
Fumiaki Ishibashi, Sho Suzuki, Mizuki Nagai, Kentaro Mochida, Tetsuo Morishita. Optimizing Helicobacter pylori Treatment: An Updated Review of Empirical and Susceptibility Test-Based Treatments. Gut and Liver 2023; 17(5): 684 doi: 10.5009/gnl220429
|
3 |
Jeong Hoon Lee, Byung‐Hoon Min, Eun Jeong Gong, Jun Young Kim, Hee Kyong Na, Ji Yong Ahn, Do Hoon Kim, Kee Don Choi, Yang Won Min, Hyuk Lee, Jun Haeng Lee, Hwoon‐Yong Jung, Jae J. Kim. Culture‐based susceptibility‐guided tailored versus empirical concomitant therapy as first‐line Helicobacter pylori treatment: A randomized clinical trial. United European Gastroenterology Journal 2024; 12(7): 941 doi: 10.1002/ueg2.12609
|
4 |
Antonio Mestrovic, Nikola Perkovic, Ante Tonkic, Zeljko Sundov, Marko Kumric, Josko Bozic. Personalized Approach in Eradication of Helicobacter pylori Infection. Antibiotics 2022; 12(1): 7 doi: 10.3390/antibiotics12010007
|
5 |
Joon Sung Kim, Byung‐Wook Kim, Jin Il Kim, Woo Chul Chung, Sung Woo Jung, Chang Seok Bang, Gwang Ha Kim, Seon Woo Jeon, Moon Kyoung Joo, Si Hyung Lee, Yun Jeong Lim, Jae Kyu Sung, Seung Young Seo, Sun Young Park, Wan Sik Lee, Hang Lak Lee, Ki Bae Kim, Heung Up Kim. Empirical Therapy Versus Tailored Therapy of Helicobacter pylori in Korea: Results of the K‐CREATE Study. Helicobacter 2024; 29(4) doi: 10.1111/hel.13126
|
6 |
Ho-Yu Ng, Wai K. Leung, Ka-Shing Cheung. Antibiotic Resistance, Susceptibility Testing and Stewardship in Helicobacter pylori Infection. International Journal of Molecular Sciences 2023; 24(14): 11708 doi: 10.3390/ijms241411708
|
7 |
Meng Li, Xiaolei Wang, Wenting Meng, Yun Dai, Weihong Wang. Empirical versus tailored therapy based on genotypic resistance detection for Helicobacter pylori eradication: a systematic review and meta-analysis. Therapeutic Advances in Gastroenterology 2023; 16 doi: 10.1177/17562848231196357
|
8 |
Theodore Rokkas, Konstantine Ekmektzoglou, David Y. Graham. Current role of tailored therapy in treating Helicobacter pylori infections. A systematic review, meta‐analysis and critical analysis. Helicobacter 2023; 28(1) doi: 10.1111/hel.12936
|
9 |
Hong-Lu Yu, Dong-Shuai Su, Shao-Ze Ma, Xing-Shun Qi. Approaches for detection of antibiotic resistance of Helicobacter pylori: Recent research advances. World Chinese Journal of Digestology 2023; 31(14): 571 doi: 10.11569/wcjd.v31.i14.571
|
10 |
Younghee Choe. Antibiotic Resistance and Helicobacter pylori Eradication Therapy. The Korean Journal of Helicobacter and Upper Gastrointestinal Research 2023; 23(3): 218 doi: 10.7704/kjhugr.2023.0044
|
11 |
Olga P. Nyssen, Marta Espada, Javier P. Gisbert. Empirical vs. Susceptibility-Guided Treatment of Helicobacter pylori Infection: A Systematic Review and Meta-Analysis. Frontiers in Microbiology 2022; 13 doi: 10.3389/fmicb.2022.913436
|